GlassScriptPhysician profile
Betsy Place
NPI 1477110955
$1,993.42
in general payments reported to CMS, 2019-2025
24 companies · $316 in 2025
The $316 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $253 · 2020: $187 · 2021: $106 · 2022: $328 · 2023: $405 · 2024: $399 · 2025: $316.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,119.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sumitomo Pharma America, INC. | $258.16 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $199.21 | 2022 | |
| Hologic Sales and Service, LLC | $190.80 | 2021-2024 | Acessa Provu System |
| Therapeuticsmd, INC. | $180.23 | 2019-2020 | |
| Astellas Pharma US INC | $154.40 | 2023-2025 | Veozah |
| Conmed Corporation | $128.43 | 2019-2021 | |
| Axonics, INC. | $109.26 | 2023 | Axonics |
| Lupin INC. | $88.66 | 2019 | |
| Sage Therapeutics, LLC | $85.59 | 2020 | |
| Exeltis, USA INC. | $72.63 | 2023-2025 | Slynd |
| Merck Sharp & Dohme LLC | $70.70 | 2023 | Lynparza |
| Minerva Surgical, INC | $65.88 | 2022 | |
| Medicem INC. | $62.68 | 2022 | |
| Biogen, INC. | $57.85 | 2025 | Zurzuvae |
| Coopersurgical, INC. | $56.94 | 2023-2025 | Paragard T 380a, Paragard T 380a |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $50.33 | 2023-2024 | |
| Heron Therapeutics, INC. | $26.01 | 2023 | Zynrelef |
| Organon LLC | $25.84 | 2024-2025 | Nexplanon, Jada System |
| Abbvie INC. | $21.53 | 2025 | |
| Exact Sciences Corporation | $20.86 | 2024 | Cologuard Collection Kit |
| Coloplast Corp | $19.22 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $18.05 | 2024 | Exparel |
| Millicent US INC | $15.69 | 2025 | Femlyv |
| Pfizer INC. | $14.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Place listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.